Cargando…
Per-protocol analysis of the ZINC trial for HIV disease among alcohol users
BACKGROUND: The Zinc for INflammation and Chronic disease in HIV (ZINC) trial randomized person who live with HIV (PLWH) who engage in heavy drinking to either daily zinc supplementation or placebo. The primary outcome was change in the Veterans Aging Cohort Study (VACS) index, a predictor of mortal...
Autores principales: | Lodi, Sara, Freiberg, Matthew, Gnatienko, Natalia, Blokhina, Elena, Yaroslavtseva, Tatiana, Krupitsky, Evgeny, Murray, Eleanor, Samet, Jeffrey H., Cheng, Debbie M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989012/ https://www.ncbi.nlm.nih.gov/pubmed/33757560 http://dx.doi.org/10.1186/s13063-021-05178-9 |
Ejemplares similares
-
Design of a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia
por: Tindle, Hilary A., et al.
Publicado: (2020) -
Effect of Zinc Supplementation vs Placebo on Mortality Risk and HIV Disease Progression Among HIV-Positive Adults With Heavy Alcohol Use: A Randomized Clinical Trial
por: Freiberg, Matthew S., et al.
Publicado: (2020) -
Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial
por: Tindle, Hilary A., et al.
Publicado: (2022) -
Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naïve persons with alcohol use in Russia
por: Barocas, Joshua A., et al.
Publicado: (2019) -
2232. Zinc deficiency and advanced liver fibrosis among HIV/HCV co-infected persons in Russia
por: Barocas, Joshua, et al.
Publicado: (2018)